BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
933 results:

  • 1. Noise suppression of proton magnetic resonance spectroscopy improves paediatric brain tumour classification.
    Zhao T; Grist JT; Auer DP; Avula S; Bailey S; Davies NP; Grundy RG; Khan O; MacPherson L; Morgan PS; Pizer B; Rose HEL; Sun Y; Wilson M; Worthington L; Arvanitis TN; Peet AC
    NMR Biomed; 2024 Jun; 37(6):e5129. PubMed ID: 38494431
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline.
    Kang HA; Wang B; Barner JC; Ataga KI; Mignacca RC; Chang A; Zhang Y
    JAMA Intern Med; 2024 May; 184(5):510-518. PubMed ID: 38466269
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neutrophilic Dermatosis of the Hands: A Case Report.
    Yaghoobi R; Bagherani N; R Smoller B; Pazyar N
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):148-50. PubMed ID: 38439725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chronic Myeloid leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
    Shah NP; Bhatia R; Altman JK; Amaya M; Begna KH; Berman E; Chan O; Clements J; Collins RH; Curtin PT; DeAngelo DJ; Drazer M; Maness L; Metheny L; Mohan S; Moore JO; Oehler V; Pratz K; Pusic I; Rose MG; Shomali W; Smith BD; Styler M; Talpaz M; Tanaka TN; Tantravahi S; Thompson J; Tsai S; Vaughn J; Welborn J; Yang DT; Sundar H; Gregory K
    J Natl Compr Canc Netw; 2024 Feb; 22(1):43-69. PubMed ID: 38394770
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
    Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
    Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
    Lee MH; Song A; Li JY
    Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.
    Chan O; Al Ali N; Tashkandi H; Ellis A; Ball S; Grenet J; Hana C; Deutsch Y; Zhang L; Hussaini M; Song J; Yun S; Talati C; Kuykendall A; Padron E; Walker A; Roboz G; Desai P; Sallman D; Sweet K; Komrokji R; Lancet J
    Blood Adv; 2024 Mar; 8(5):1075-1083. PubMed ID: 38170740
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]    [Full Text] [Related]  

  • 9. Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.
    Jones RR; Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; McGlynn KA; Sampson J; Albert PS; Ward MH
    J Natl Cancer Inst; 2024 May; 116(5):728-736. PubMed ID: 38092046
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Scope of Practice of an Embedded Pediatric Palliative Oncology Clinic.
    Park HS; DeGroote NP; Lange A; Kavalieratos D; Brock KE
    J Pain Symptom Manage; 2024 Mar; 67(3):250-259.e5. PubMed ID: 38065424
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lifestyle and subsequent meningioma in childhood cancer survivors: A report from the St. Jude Lifetime Cohort study.
    Onerup A; Mirzaei S S; Bhatia S; Ware ME; Joffe L; Turcotte LM; Goodenough CG; Sapkota Y; Dixon SB; Wogksch MD; Ehrhardt MJ; Armstrong GT; Hudson MM; Ness KK
    Cancer Rep (Hoboken); 2024 Jan; 7(1):e1944. PubMed ID: 38009808
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studies.
    Belle FN; Schindera C; Ansari M; Armstrong GT; Beck-Popovic M; Howell R; Leisenring WM; Meacham LR; Rössler J; Spycher BD; Tonorezos E; von der Weid NX; Yasui Y; Oeffinger KC; Kuehni CE
    Cancer Med; 2023 Oct; 12(20):20423-20436. PubMed ID: 37807946
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.
    Satty AM; Klein E; Mauguen A; Kunvarjee B; Boelens JJ; Cancio M; Curran KJ; Kernan NA; Prockop SE; Scaradavou A; Spitzer B; Tamari R; Ruggiero J; Torok-Castanza J; Mehta PA; O'Reilly RJ; Boulad F
    Bone Marrow Transplant; 2024 Jan; 59(1):23-33. PubMed ID: 37773270
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country.
    Farrag A; Ghazaly MH; Mohammed K; Volland R; Hero B; Berthold F
    BMC Pediatr; 2023 Sep; 23(1):443. PubMed ID: 37670249
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival.
    Löfstedt A; Jädersten M; Meeths M; Henter JI
    Blood; 2024 Jan; 143(3):233-242. PubMed ID: 37595287
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer.
    Fernández-Castillejo S; Roig B; Melé M; Serrano S; Salvat M; Querol M; Brunet J; Pineda M; Cisneros A; Parada D; Badia J; Borràs J; Rodríguez-Balada M; Gumà J
    J Med Genet; 2023 Dec; 61(1):69-77. PubMed ID: 37591735
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
    Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
    Hilton LK; Ngu HS; Collinge B; Dreval K; Ben-Neriah S; Rushton CK; Wong JCH; Cruz M; Roth A; Boyle M; Meissner B; Slack GW; Farinha P; Craig JW; Gerrie AS; Freeman CL; Villa D; Rodrigo JA; Song K; Crump M; Shepherd L; Hay AE; Kuruvilla J; Savage KJ; Kridel R; Karsan A; Marra MA; Sehn LH; Steidl C; Morin RD; Scott DW
    J Clin Oncol; 2023 Sep; 41(25):4164-4177. PubMed ID: 37319384
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas.
    Bhansali RS; Barta SK
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):642-650. PubMed ID: 37302955
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Maternal morbidity and mortality among patients with cancer at time of delivery.
    Sundermann AC; Cate JM; Campbell AK; Dotters-Katz SK; Myers ER; Federspiel JJ
    Am J Obstet Gynecol; 2023 Sep; 229(3):324.e1-324.e7. PubMed ID: 37295633
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 47.